Budesonide
Budesonide is a pharmaceutical drug with 161 clinical trials. Currently 8 active trials ongoing. Historical success rate of 91.1%.
Success Metrics
Based on 113 completed trials
Phase Distribution
Phase Distribution
23
Early Stage
37
Mid Stage
81
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
84.3%
113 of 134 finished
15.7%
21 ended early
8
trials recruiting
161
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
A Study to Evaluate the Efficacy and Safety of QMF149 (Indacaterol Acetate/Mometasone Furoate) Versus Budesonide in Children From 6 to Less Than 12 Years of Age With Asthma
Budesonide Prophylaxis for Engraftment Syndrome After Hematopoietic Cell Transplantation
Once Daily Versus Twice Daily Budesonide Orodispersible Tablets for Induction of Remission in EoE
Inflammatory Profiles, Histopathological Features, and Remodeling Factors in Chronic Rhinosinusitis With Nasal Polyps
Molecular Signatures Associated With Response to ICS Treatment in Patients With COPD Stratified by Eosinophil Levels
Clinical Trials (161)
A Study to Evaluate the Efficacy and Safety of QMF149 (Indacaterol Acetate/Mometasone Furoate) Versus Budesonide in Children From 6 to Less Than 12 Years of Age With Asthma
Budesonide Prophylaxis for Engraftment Syndrome After Hematopoietic Cell Transplantation
Once Daily Versus Twice Daily Budesonide Orodispersible Tablets for Induction of Remission in EoE
Inflammatory Profiles, Histopathological Features, and Remodeling Factors in Chronic Rhinosinusitis With Nasal Polyps
Molecular Signatures Associated With Response to ICS Treatment in Patients With COPD Stratified by Eosinophil Levels
Predicting Post Extubation Stridor After Maxillomandibular Fixation
Little Lungs Study
Front Line Ibrutinib Without Corticosteroids for Newly Diagnosed Chronic Graft-versus-Host Disease
Dupilumab in Chinese Adult Participants With CRSwNP
Budesonide as a Treatment for Functional Dyspepsia
Evaluation of the Efficacy of Local Budesonide Treatment in Children with Crohn's Disease Located in the Esophagus And/or Stomach And/or Duodenum
A Study to Determine the Effect Food Has on TAK-721 (Budesonide Oral Suspension) in the Body of Healthy Adults
Bioequivalence of IMP 08P1707F0 Relative to Pulmicort® (1.0 Mg/2 Ml Suspension)
Cycling of Topical Steroids for Treatment of EoE (Eosinopilic Esophagitis)
Diesel Exhaust Induces Glucocorticoid Resistance
Treatment of Pediatric Patients That Lost Sense of Smell Due to COVID-19
Assessment Of Dose-Dependent Immunomodulatory Effect Of Alveofact With or Without Steroisd In Neonatal RDS
Acupuncture Therapy for COVID-Related Olfactory Loss
Comparison of Preoperative Inhaled Budesonide With Salbutamol on the Respiratory Adverse Effects in Children Undergoing Tonsillectomy
Replication of the D58 Asthma Trial in Healthcare Claims Data
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 161